1 4 0 7 a r t I C l e S Every year in the US alone, an estimated 1.7 million people sustain acute brain injury from trauma and, of those, 52,000 die and 85,000 suffer from long-term disabilities 1,2 . This includes injuries from many etiologies, such as road traffic accidents, falls, assaults and sports concussions. In addition, the RAND Corporation estimates that over 400,000 US soldiers have suffered TBI in Operation Iraqi Freedom and Operation Enduring Freedom 3 . A specific therapy for TBI does not yet exist, and standard treatment remains supportive in nature. Like many forms of acute brain injury, TBI involves primary injury, which is felt to be refractory to treatment, and secondary injury, characterized by a cascade of biochemical and cellular events contributing to neuronal damage over time 4 . Secondary injury involves multiple pathways of neuronal death that represent viable therapeutic targets 5, 6 .
a r t I C l e S the number of non-oxidized cardiolipin species decreased to ~100, whereas that of oxidized species increased to 166 (Fig. 1b) . Quantitatively, the content of oxidized cardiolipin species increased 20-fold at the expense of decreased amounts of non-oxidized cardiolipin ( Fig. 1c and Supplementary Table 1 ). This oxidation effect was specific to cardiolipin, as other, more abundant polyunsaturated phospholipids, phosphatidylcholine and phosphatidylethanolamine, remained non-oxidized (Supplementary Fig. 1 ). Clusters of oxidized cardiolipin were also observed in the 2D-LC-MS lipidomics profile in a human brain sample after TBI (Supplementary Fig. 2 ). The scale of CCI-induced oxidative changes in cardiolipin far exceeded the detectable, but much less pronounced, decreases of the levels of glutathione (GSH) and protein sulfhydryls (PSH) in the rat brain ( Supplementary  Fig. 3a,b) . The decrease in GSH levels after CCI could be associated with responses to accumulation of cardiolipin hydroperoxides by mitochondrial GSH peroxidase IV that are known to catalytically reduce cardiolipin hydroperoxides at the expense of GSH 12, 13 .
To gain further insight into the role of cardiolipin and its oxidation in CCI induced damage, we used an in vitro TBI model of mechanical stretch injury in rat primary cortical neurons. Mechanical stretch triggered robust and selective peroxidation of cardiolipin ( Supplementary  Fig. 3c ), but not phosphatidylcholine or phosphatidylethanolamine, which comprise 49% and 30%, respectively, of total phospholipids in primary neurons. Stretch decreased neuronal viability, as assessed by lactate dehydrogenase (LDH), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Trypan blue exclusion assays ( Fig. 2a and Supplementary Figs. 4 and 5a) , microtubule-associated protein 2 (MAP-2, neuronal cytoskeleton marker) and cleaved caspase 3 immunostaining ( Supplementary Fig. 5b,c) , and measurements of caspase 3/7 activity (Fig. 2b) , cyt c release (Fig. 2c) , annexin V and a c b npg a r t I C l e S propidium iodide positivity (Fig. 2d,e) . Notably, exposure of primary neurons to oxidized cardiolipin (but not to non-oxidized cardiolipin) resulted in dose-dependent cell death (P < 0.01; Fig. 3) .
We then used an RNAi approach to manipulate the content of cardiolipin in neurons by knocking down cardiolipin synthase ( Supplementary Fig. 6a ), the key enzyme of de novo cardiolipin biosynthesis, and assessed the neurons' responses to stretch. The cardiolipin content decreased to 44% of its level in parental cells (Supplementary Fig. 6b ), whereas the ATP content did not change (Supplementary Fig. 6c) . Notably, characteristic markers of stretchinduced cell death, elevated caspase 3/7 activity, release of cyt c from mitochondria into the cytosol, increased annexin V positivity, and release of LDH, were all attenuated and cell survival was increased in cardiolipin-deficient cells (Fig. 2a-d and Supplementary Fig. 5 ). Previously, we found that cell death-associated cardiolipin oxidation was catalyzed by peroxidase activity of the cyt c-cardiolipin complex 9 . With this in mind, we generated cyt c-deficient primary neuronal cells (Supplementary Fig. 6d ) and examined their vulnerability to stretch-induced damage as compared with control cells. Sensitivity of cyt c-deficient neurons to stretch was lower than that of parental cells, as evidenced by caspase 3/7 activity, cyt c release, annexin V positivity and cell viability (Fig. 2a-d and Supplementary Fig. 5 ). Taken together, these in vitro results are compatible with our hypothesis that cardiolipin oxidation, possibly catalyzed by cyt c, was involved in TBI-induced damage of neurons.
XJB-5-131 targets brain mitochondria
Because mutation or suppression of cardiolipin synthesis and cyt c are therapeutically impractical, we hypothesized that inhibition of cardiolipin peroxidation could attenuate neuronal death and brain injury. This might be achieved by targeting electron scavengers, which will prevent formation of H 2 O 2 , the fuel for cyt c and cardiolipin peroxidase, in the mitochondria. We designed mitochondria-targeted nitroxide payloads conjugated to selective transporters into mitochondria 14 . We reasoned that these mito-nitroxides could represent effective therapeutic agents for brain injury if they accumulate in mitochondria and prevent oxidative damage, penetrate into the CNS and accumulate in the brain tissue, and display low toxicity and high neuroprotective potential. To this end, we used XJB-5-131 ( Supplementary Fig. 3d ), a conjugate of 4-amino TEMPO and the chemically modified segment of a bacterial membrane targeting antibiotic Gramicidin S, which effectively delivered the nitroxide into mitochondria. The characteristic triplet electron paramagnetic resonance (EPR) signal of Gramicidin S-nitroxide was detected almost a b npg a r t I C l e S exclusively in the mitochondrial fraction of primary cortical neurons treated with XJB-5-131 (Fig. 4a) , and cell viability was not affected (Supplementary Fig. 4 ).
To evaluate CNS penetration of XJB-5-131, we measured the drug concentration in cerebrospinal fluid (CSF) by EPR spectroscopy. Typical nitroxide signals were detected in CSF when XJB-5-131 (10 mg per kg of body weight) was administered intravenously to naive postnatal day 17 (P17) rats (Fig. 4b) . At 30 min after injection, the total concentration of nitroxide and its reduced form (revealed in the presence of ferricyanide) in CSF was 1.4 ± 0.1 nM (mean ± s.d.). By employing micro-computerized tomography and L-Band in vivo EPR imaging, we documented a time-and dose-dependent distribution of XJB-5-131 in naive P17 rat brains after intravenous injection (Fig. 4c) . We used mass spectrometric imaging and confirmed the presence of XJB-5-131 in the brain tissue after a single intravenous dose (Fig. 4d) . Finally, direct quantification of XJB-5-131 in the brain tissue by LC-MS also revealed its accumulation to a level of 16.5 ± 4.3 pmol g −1 of tissue (mean ± s.d.) at 3 h after a single 10 mg per kg intravenous injection.
XJB-5-131 protects cardiolipin and improves behavior
We further examined whether XJB-5-131 would inhibit TBIinduced cardiolipin oxidation. We found that cardiolipin oxidation was almost completely blocked by XJB-5-131 administered 10 min after TBI (Fig. 1) . The number of non-oxygenated and oxygenated species was comparable to those in control brain. Quantitatively, the amounts of non-oxidized and oxidized cardiolipins remained similar to those in the non-traumatized brain (Fig. 1c) . In addition, XJB-5-131 protected brain thiols, GSH and PSH, oxidized by TBI 15, 16 ( Supplementary Fig. 3a) .
Given the ability of XJB-5-131 to protect against cardiolipin oxidation, we evaluated its neuroprotective potential in TBI and performed neurobehavioral testing on P17 rats subjected to CCI injury.
We assessed motor function with the well-established beam balance and inclined platform tasks and evaluated cognitive performance using novel object recognition (NOR) and Morris water maze tests, which are sensitive to motor and cognitive function and/or dysfunction after TBI [17] [18] [19] . Balancing ability or inclined platform performance did not differ among groups before surgery (Fig. 5a,b) , suggesting that pre-training was consistent among all groups. However, after surgery, a significant improvement in motor performance (with both tasks, P ≤ 0.0001) was observed on days 3-5 in the sham and CCI + XJB-5-131 groups compared with the CCI + vehicle group (Fig. 5a,b) . Although all groups began at a similar level in the water maze, both the CCI + XJB-5-131 and sham groups performed progressively better than the CCI + vehicle group. This cognitive benefit was observed during both the acute and subchronic phases of training, which correspond to post-injury days 11-15 and 30-34, respectively (P < 0.001; Fig. 5c and Supplementary Fig. 7a) . Although the rats treated with XJB-5-131 found the platform significantly faster than vehicle-treated rats (P < 0.001, N = 7-10 rats per group), the time spent searching in the target quadrant during a single probe trial was not statistically different between the two groups (P = 0.09, N = 7-10 rats per group). To further assess memory retention, we used the NOR memory test on post-operative day 29. XJB-5-131-treated rats spent significantly more time exploring the novel object than the vehicle-treated rats (P < 0.01; Fig. 5d ). Swim speed did not differ among groups (P = 0.12), indicating that water maze or NOR test performance were not influenced by differences in swimming or motor ability or motivational deficits. npg a r t I C l e S
XJB-5-131 attenuates apoptotic neuronal death
To evaluate the potency of XJB-5-131 in preventing neuronal death, we employed Fluoro-Jade C staining (Fig. 5e) , which is commonly used to detect degenerating neurons regardless of the specific cell death pathway 20 . The number of Fluoro-Jade C-positive cells increased at 24 h as compared with 3 h after TBI and naive or sham. Fluoro-Jade C positivity was observed predominantly in the pericontusional area and was significantly attenuated by treatment with XJB-5-131 (P < 0.05). Furthermore, cortical lesion volume was significantly decreased at 5 weeks in the TBI group treated with XJB -5-131 as compared with the TBI group that received vehicle (P < 0.05; Supplementary Fig. 7b ).
To better define the possible cell death pathways responsible for neuronal degeneration and the effect of XJB-5-131 in vivo, we examined caspase 3/7 activity. Ipsilateral cortical caspase 3/7 activity was increased at 24 h (but not at 3 h) after CCI (Supplementary Fig. 8 ). This effect was attenuated by XJB-5-131, pointing to its anti-apoptotic mechanism of action. Similarly, treatment with XJB-5-131 (5, 10 and 25 µM) attenuated stretch-induced neuronal death ( Supplementary  Figs. 4 and 5) via suppression of mitochondrial superoxide production (Supplementary Fig. 9a ) and stretch-induced cyt c release into the cytosol (Supplementary Fig. 9b ). 4-amino-TEMPO, the active nitroxide part of XJB-5-131, but which lacks the mitochondria-targeting hemigramicidin moiety, failed to protect against stretch-induced neuronal death (Fig. 6) , suggesting that mitochondrial damage was involved in neuronal cell death.
XJB-5-131 acts as an electron scavenger
The two likely mechanisms of XJB-5-131's action in the brain are either as a superoxide dismutase (SOD)-mimetic, catalyzing the dismutation of superoxide radicals into H 2 O 2 , or as an electron scavenger, preventing one-electron reduction of molecular oxygen to superoxide.
In the former case, XJB-5-131 would retain its radical state, whereas in the latter case, XJB-5-131 would be reduced to hydroxylamine. In different redox environments, dynamic interconversions between the nitroxide and hydroxylamine forms occur, resulting in the establishment of an equilibrium between the two. This equilibrium is readily detectable by EPR spectra of the nitroxides (Fig. 7) . Nitroxide radicals elicit a characteristic EPR signal with hyperfine splitting constants of 16.4 G (a N ). In contrast, hydroxylamines are EPR silent and produce no signals in the spectrum. A characteristic triplet EPR signal (Fig. 7a) from nitroxide radicals disappeared and was substituted by a typical doublet signal of ascorbate radicals (with hyperfine splitting constants of 1.84 G) following reduction of nitroxides. This signal of ascorbate radicals disappeared upon addition of ascorbate oxidase. As potent reductants, hydroxylamines are readily oxidized by metalloproteins in their higher valency states (for example, Fe(III)-cyt c) and even more so by their reactive intermediates (for example, oxo-ferryls Fe(IV) = O produced in the presence of H 2 O 2 ). Indeed, addition of oxidized ferri-cytochrome c or cyt c/H 2 O 2 , to hydroxylamine (produced by the ascorbate-driven reduction of the nitroxide with subsequent elimination of excess ascorbate by ascorbate oxidase), resulted in one-electron oxidation of hydroxylamines and re-appearance of the characteristic nitroxide EPR signals.
We also observed these interconversions between hydroxylamines and nitroxides in brain homogenates (Fig. 7b) . Addition of the nitroxide to brain homogenate produced a typical ascorbate radical signal as a result of the reaction with endogenous ascorbate 16 . After pretreatment of the homogenate with ascorbate oxidase, the addition of the nitroxide immediately yielded the characteristic triplet signal of the nitroxide radical. Notably, triggering NADH-dependent transport of electrons resulted in substantial suppression of the EPR signal of nitroxides as a result of their reduction by electron transport chain. Finally, the redox interconversion between the nitroxide (>N-O*) and hydroxylamine (>N-OH) functionalities is a H + -dependent process, whereby, in the pH range of 6-7, deprotonation of the hydroxylamine (>N+H-OH) markedly accelerates its auto-oxidation to nitroxide 21, 22 . This suggests that, in the basic environment of mitochondria (pH~8.0), targeted XJB-5-131 hydroxylamine will npg a r t I C l e S spontaneously undergo auto-oxidation to the respective nitroxide (Fig. 7c) . Furthermore, using LC-MS-based quantification, we found that nearly all XJB-5-131 (91.7 ± 14.5%) was present in the hydroxylamine form and the nitroxide represented only a small fraction of total XJB-5-131. Given that the hemigramicidin S-derived alkene peptide isostere sequence in XJB-5-131 is responsible for its predominant localization in mitochondria, its action likely occurs through the scavenging of electrons leaking from discoordinated electron carriers, rather than through involvement of SOD-like activity.
DISCUSSION
For decades, oxidative stress has been implicated in acute brain injury 10, 23, 24 , which has prompted some of the earliest randomized controlled trials in the field of TBI 25 . However, limitations with specificity, potency, blood-brain barrier and/or cell penetration with conventional antioxidant approaches may have contributed to these past treatment failures 26 . Our results identify selective peroxidation of cardiolipin as an important pathogenic mechanism for TBI. The peroxidation process yields a high diversity of oxidized cardiolipin products that may be required to activate the neuronal death program.
Redistribution of cardiolipin from the inner mitochondrial membrane to the outer mitochondrial membrane and subsequent accumulation of cardiolipin oxidation products, catalyzed by cyt c, are required stages in the execution of the intrinsic apoptotic program 9,27-31 . Oxidized cardiolipin (but not non-oxidized cardiolipin) causes the release of pro-apoptotic factors, including cyt c, from mitochondria into the cytosol and caspase activation 32 . The mechanisms of mitochondrial membrane permeabilization triggered by oxidized cardiolipin may involve interactions with several outer membrane proteins (for example, Bax, Bak and VDAC) [33] [34] [35] . It is likely that cardiolipin peroxidation is not a result of the aftermath of cell death, but is instead causative to it, thus offering an opportunity for a targeted therapy. Indeed, we found that mitochondrial delivery of small molecule inhibitors, electron scavengers, led to the prevention of both accumulation of a large number of cardiolipin oxidation products, as well as brain damage. The use of the mitochondria-targeted nitroxides offers considerable therapeutic advantages compared with previously used strategies, in terms of getting to the source of oxidative stress at an early point with the highest specificity and the least toxicity and possibly limiting deleterious effects on oxidative signaling in other brain lipids.
Stable nitroxide radicals combine electron and free radical scavenging actions with SOD-mimicking and recycling capacities. One of these nitroxides, Tempol, has been shown to improve motor function after experimental TBI 36 ; however, high millimolar concentrations were required to attain this improvement. Depending on the redox environment, nitroxides may be present in three major forms: oxidized (oxoammonium cation, RN + = O), semi-reduced (the nitroxide radical, RN-O•) and reduced (the hydroxylamine, RN-OH) 37 . Accordingly, there are three major biochemical mechanisms of action for nitroxides. First, superoxide anion-radical-driven interconversions between 1↔2 underlie the SOD-mimicking activity of nitroxides 38 . This catalytic activity regenerates the nitroxide form of the compound; no reduced form, hydroxylamine, is produced in this reaction. Second, electron scavenging occurs from other reductants, particularly reduced respiratory complexes of mitochondria. This mechanism prevents leakage of electrons from electron transport chains to molecular oxygen (thus, the formation of superoxide radicals) and yields hydroxylamines via a one-electron reduction process. In extra-mitochondrial compartments, ascorbate is the most abundant low molecular weight reductant of nitroxides, whereas the reactivity of GSH and other thiols is much lower 39 . Third, interactions of hydroxylamines with oxidizing radicals, oxidized intermediates of peroxidases, or oxidized forms of transition metals or metalloproteins yield the nitroxide. For example, reduction of hydroxylamines by oxidizing radicals, such as peroxyl, alkoxyl or ferri-cytochrome c, converts hydroxylamines back to their nitroxide forms 22, 40, 41 . We performed EPR spectroscopy to more clearly illustrate these interconversions of nitroxides and hydroxylamines. Notably, these interconversions between hydroxylamines and nitroxides can be observed in brain homogenates.
It is known that the immature brain has compromised antioxidant defenses compared with adults 42 , implying that the beneficial effects of XJB-5-131 could potentially be magnified in the developing brain. Given the enormous burden of TBI in pediatrics, our use of a developmental TBI model may be of additional clinical relevance. Germane to our findings, considerable mitochondrial dysfunction with altered bioenergetics 43 , increased oxidative stress markers 44 , membrane permeabilization 45 and release of proapoptotic factors 46 have been observed in both experimental models and humans after severe TBI. There is accumulating evidence supporting a role of TBI as a trigger for a number of neurodegenerative diseases, such as dementia 47 , amyotrophic lateral sclerosis and Parkinson's disease 48 . Given the role of oxidative stress across the field of brain injury, our results suggest that cardiolipin peroxidation may be characteristic of other types of acute brain injury, such as that seen in stroke and cardiac arrest. Thus, this mechanism and the linked new therapeutic approach are relevant to other forms of CNS injury.
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Methods and any associated references are available in the online version of the paper.
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